ArticleMDM policy & practice
Estimating Chronic Kidney Disease Stage Transitions from Irregular Electronic Health Record Data Using an Expectation-Maximization Framework.
Article in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Objective: To estimate chronic kidney disease (CKD) stage transition probabilities in patients with small renal masses (SRMs) using irregularly observed electronic health record (EHR) data, addressing challenges of interval censoring and irregular measurement intervals in real-world clinical practice. Data Sources: We used EHR data from the institutional Small Renal Mass registry (2006-January 2026), capturing outpatient renal function data prior to any definitive treatment for SRM. CKD stages were defined using estimated glomerular filtration rate (eGFR) thresholds based on KDIGO guidelines. Study Design: The final analytic cohort included 527 patients with at least 2 outpatient eGFR measurements prior to definitive treatment. We applied an expectation-maximization (EM) algorithm to estimate discrete-time CKD stage transition matrices while accounting for irregular eGFR measurement intervals and unobserved intermediate transitions. Transition matrices were estimated under 3- and 6-mo cycle lengths overall as well as stratified by age and sex. The likelihood ratio statistic was used to compare EM-based estimates with the empirical counting estimator. Results: The EM framework yielded clinically plausible transition structures dominated by self-transitions and progression primarily to adjacent CKD stages, with reduced spurious backward transitions relative to the empirical estimator. Transition patterns were consistent across 3- and 6-mo cycle lengths. Age-stratified analyses showed that older patients had slightly higher probabilities of progression to more advanced CKD stages compared with younger patients, whereas sex-stratified differences were minimal. Likelihood ratio comparisons supported the consistency of the EM-based models with the observed transition data in both the overall cohort and subgroup analyses. Conclusions: The EM approach provides a principled and computationally efficient method for estimating CKD stage progression from irregularly observed EHR data, yielding transition matrices suitable for discrete-time decision-analytic and health economic models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.